Cargando…
A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1)
BACKGROUND AND PURPOSE: Preoperative 5-fluorouracil-based chemoradiotherapy is a standard treatment for locally advanced lower rectal cancer (LALRC). We performed a phase I study to develop a new regimen combining irinotecan and S-1. MATERIALS AND METHODS: Patients with LALRC (T3-4, N0-2) were studi...
Autores principales: | Sato, Takeo, Hayakawa, Kazushige, Tomita, Naohiro, Noda, Masafumi, Kamikonya, Norihiko, Watanabe, Toshiaki, Kato, Daiki, Sakai, Yoshiharu, Hiraoka, Masahiro, Shimada, Mitsuo, Ikushima, Hitoshi, Baba, Hideo, Oya, Natsuo, Oya, Masatoshi, Nemoto-Murofushi, Keiko, Takeuchi, Masahiro, Watanabe, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Scientific Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013752/ https://www.ncbi.nlm.nih.gov/pubmed/27317556 http://dx.doi.org/10.1016/j.radonc.2016.06.002 |
Ejemplares similares
-
Phase 1b trial of proteasome inhibitor carfilzomib with irinotecan in lung cancer and other irinotecan-sensitive malignancies that have progressed on prior therapy (Onyx IST reference number: CAR-IST-553)
por: Arnold, Susanne M., et al.
Publicado: (2017) -
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer
por: Doi, Toshihiko, et al.
Publicado: (2015) -
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer
por: Okamoto, Isamu, et al.
Publicado: (2009) -
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors
por: Takahashi, Toshiaki, et al.
Publicado: (2012) -
First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors
por: Doi, Toshihiko, et al.
Publicado: (2018)